// 10 — us healthcare markets

US Healthcare Markets

The business side of US healthcare: insurance, hospitals, physicians, pharma, devices, and how new technology gets evaluated and paid for. 22 topics that follow the UMN Healthcare Marketplace specialization, lecture by lecture.
Total
22
Done
0
Progress
0%
Left
22
Est. time
~24 h

1 · Healthcare Marketplace — Parente

market 0/5 ▾

Evolution of the healthcare marketplace

Economic history of US healthcare, spending and quality trends, the stakeholders, and how regulation creates or destroys markets.
Course 1 · Module 1 — Parente

Physician & hospital services market

The largest share of spending. Market power, price discrimination, barriers to entry, hospital reimbursement.
Course 1 · Module 2 — Parente · An American Sickness, ch. 2–3

The insurance market

Risk pooling, moral hazard, adverse selection, the uninsured, and a century of US health reform.
Course 1 · Module 3 — Parente · An American Sickness, ch. 1

Medical technology markets

Devices vs drugs, development and regulatory costs, FDA pathways, IP, revenue models, cost-effectiveness.
Course 1 · Module 4 — Parente

Global medical innovation

Globalization, medical tourism, health IT for payers and providers, and a checklist for valuing an innovation.
Course 1 · Module 5 — Parente

2 · Healthcare Delivery Providers — Koranne

delivery 0/5 ▾

US healthcare delivery — lenses, Quadruple Aim & ACOs

Sites of care, people, payment and payers as lenses. Triple and Quadruple Aim. How ACOs work and what they taught.
Course 2 · Module 1 — Koranne

Hospitals — community & specialty

Organization, services, payment and performance (quality, satisfaction, financials). Critical access hospitals, ASCs, freestanding EDs.
Course 2 · Module 2 — Koranne · An American Sickness, ch. 2

Post-acute & community-based care

Care after discharge: LTACHs, inpatient rehab, SNFs, home health, hospice, and community services.
Course 2 · Module 3 — Koranne

Physicians — primary, specialty & new settings

Primary and specialty care, payment and measurement, the medical home, retail clinics, virtual and urgent care.
Course 2 · Module 4 — Koranne · An American Sickness, ch. 3

Healthcare delivery of tomorrow

Stakeholders that shape delivery, county health rankings, process improvement, what future leaders need.
Course 2 · Module 5 — Koranne

3 · Pharma & Medical Device Innovations — Parente

pharma 0/4 ▾

Pharma — bench science to bedside

Drug development, intellectual property, FDA and global regulation, reimbursement in the US and abroad.
Course 3 · Module 1 — Parente · An American Sickness, ch. 4

Pharma — market deployment & management

Defining the market and customers, competitor analysis, generics and OTC, cancer drug payment in the UK vs the US.
Course 3 · Module 2 — Parente

Medical devices — bench science to bedside

Regulatory basics, device failure, the device-drug overlap, coding, payment and reimbursement strategy.
Course 3 · Module 3 — Parente · An American Sickness, ch. 5

Medical devices — market deployment & management

The 510(k) pathway, innovation pipelines, go-to-market, market share, post-market safety.
Course 3 · Module 4 — Parente

4 · Medical Technology & Evaluation — Barrette

evaluation 0/4 ▾

Technology assessment — payment & regulatory context

Why healthcare needs technology assessment, who uses the results, government vs private payers, inpatient and drug payment.
Course 4 · Module 1 — Barrette

Clinical trials vs claims data

Randomization and blinding. Elements and sources of claims data, how it differs from clinical data, and bias.
Course 4 · Module 2 — Barrette

Cost-effectiveness basics — CEA, CUA & QALYs

Types of assessment, measuring costs, measuring benefits, QALYs and quality of life.
Course 4 · Module 3 — Barrette

ICER, decision models & uncertainty

Building and reading an ICER. Bayes, discounting, decision trees, Monte Carlo and Markov models.
Course 4 · Module 4 — Barrette

5 · Capstone — a market report

capstone 0/4 ▾

Capstone 1 — the innovation & its market

Pick a medical innovation and explain why it is worth adopting or investing in.
Course 5 · Milestone 1 — Parente

Capstone 2 — the voice of the provider

Interview providers about what they would need before adopting it. A 2–3 page memo.
Course 5 · Milestone 2 — Parente

Capstone 3 — regulatory & IP status

Classify it under FDA rules and run a basic patent search with free public tools.
Course 5 · Milestone 3 — Parente

Capstone 4 — revenue & market report

Market size, provider input, IP and regulatory path, reimbursement. Is it commercially sustainable?
Course 5 · Milestone 4 — Parente

// bibliography

The books, courses and practice sites behind this roadmap.

// books
An American Sickness
Elisabeth Rosenthal · cited in 6 topics
Part I, one industry per chapter: insurance (1), hospitals (2), physicians (3), pharma (4), devices (5).
// courses
1 · Healthcare Marketplace ↗
Stephen T. Parente — UMN · cited in 5 topics
Markets for providers, insurance and medical technology. 22 hours.
2 · Healthcare Delivery Providers ↗
Rahul Koranne — UMN · cited in 5 topics
Hospitals, post-acute care, physicians, ACOs and the Quadruple Aim. 27 hours.
3 · Pharmaceutical and Medical Device Innovations ↗
Stephen T. Parente — UMN · cited in 4 topics
How drugs and devices go from lab to market and get paid for. 14 hours.
4 · Medical Technology and Evaluation ↗
Eric Barrette — UMN · cited in 4 topics
Trials vs claims data, cost-effectiveness, ICERs and decision models. 14 hours.
5 · Healthcare Marketplace Capstone ↗
Stephen T. Parente — UMN · cited in 4 topics
A market report on a real innovation, in four milestones. 14 hours.